Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
21.40
+0.39 (1.86%)
Jun 8, 2026, 10:18 AM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.32 billion as of June 8, 2026. Its market cap has increased by 33,552.96% in one year.
Market Cap
1.32B
Enterprise Value
760.33M
1-Year Change
33,552.96%
Ranking
Category
Stock Price
$21.40
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.32B, an increase of 257.19%. That is a compound annual growth rate of 25.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.29B | 3,418.58% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.37B |
| Maze Therapeutics | 1.34B |
| MoonLake Immunotherapeutics | 1.32B |
| Bicara Therapeutics | 1.31B |
| Immatics | 1.31B |
| UroGen Pharma | 1.31B |
| Maravai LifeSciences Holdings | 1.30B |
| Savara | 1.29B |